1. Home
  2. Browse
  3. Practice
  4. Legal & Licensing
  5. Drug Withdrawals/Restricted Sale

Drug Withdrawals/Restricted Sale

136 - 150 of 152 Results
Sort Results:
Article: A new Auralgan is replacing the older Auralgan May 2008
Article: People are hearing that Singulair might increase suicide risk May 2008
Article: The recent withdrawal of infant cough and cold OTCs has parents asking how to alleviate cold symptoms in young children November 2007
Patient Education: Infant Cough and Cold Products: Why Are They Gone and What Should I Do? November 2007
Commentary: Exubera Off the Market November 2007
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2007
Other: Info for Healthcare Providers About the Discontinuation of Exubera November 2007
Commentary: Concerns About OTC Cough and Cold Products in Children November 2007
Article: Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing July 2007
Article: Qualaquin, the only quinine that FDA allows on the market, is too expensive May 2007
Patient Education: Quinine and Preventing Leg Cramps May 2007
Commentary: Informed Consent for Off-Label Drug Use: Things to Consider May 2007
Commentary: Professional Information about Quinine and Leg Cramps May 2007
Commentary: Legal Analysis of Using Quinine Off-Label and Informed Consent for Leg Cramps May 2007
Article: FDA's specific warning NOT to use quinine for leg cramps could raise a legal exposure question for you January 2007